Helping patients make informed decisions about prostate cancer screening
Listen to our new KP Research Radio episode and learn more about the risks and benefits of the PSA test to screen for prostate cancer.
Kaiser Permanente
Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
5 Questions for . . . Marvin Langston
Early career researcher Marvin Langston, PhD, MPH, studies potential links between infections, inflammation, and cancer as well as racial/ethnic and sexual minority health disparities.
Kaiser Permanente researchers develop new prostate cancer risk calculator
A new prostate cancer risk calculator developed by Kaiser Permanente Northern California researchers may help men going through prostate cancer screening decide whether to have a prostate biopsy.
5 Questions for . . . Stephen Van Den Eeden
Research scientist Stephen Van Den Eeden, PhD, is a co-founder of the California Men's Health Study, one of the largest and longest-running cohort studies of men in the world.
On-demand HIV prevention pills worked well for San Francisco patients
Patients reported positive outcomes with use of an HIV prevention medication dosed only as needed, instead of the more common daily dosing, Kaiser Permanente researchers reported.
More metastatic prostate cancers found after change in screening guidelines
In the years after the U.S. Preventive Services Task Force recommended against PSA-based screening in all men, many fewer men were diagnosed with prostate cancer but more were found to have advanced cancers, according to a large Kaiser Permanente study published today in the Journal of General Internal Medicine.
First Genetic Risk Factor for Erectile Dysfunction Identified
For the first time, a team of researchers, led by Kaiser Permanente, has found a specific place in the human genome that raises a person’s risk of erectile dysfunction.
Rare Cancer Carefully Tracked and Treated
Technology allows a panel of urologists and oncologists to provide the most up-to-date treatment for every single person with testicular cancer at Kaiser Permanente Northern California.
BPA study of Chinese factory workers finds link to reduced semen quality
In 2010, a five-year Kaiser Permanente Northern California study of more than 500 male Chinese factory workers found that those with high levels of the compound bisphenol A (BPA) in their bodies had decreased sperm concentration, decreased total sperm count,…
